ROBERT HERSKOWITZ

Company

Alaunos Therapeutics, Inc.

Filed

September 27, 2005

Accession Number

0001121781-05-000230

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →